Adding another layer to the intricacies of cancer treatment, the secreted phosphoprotein 1 (SPP1), also known as osteopontin (OPN), exhibits upregulation in malignancies, correlating with treatment resistance [128]. The gene discussed is SPP1; the disease is cancer.